| Authors: |
Almeida-Correa S; Neuroscience and Mental Health Discovery Research Department, Boehringer Ingelheim Pharma GmbH, Biberach, Germany., Wesemann FS; Neuroscience and Mental Health Discovery Research Department, Boehringer Ingelheim Pharma GmbH, Biberach, Germany., Diez S; Neuroscience and Mental Health Discovery Research Department, Boehringer Ingelheim Pharma GmbH, Biberach, Germany.; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH, Biberach, Germany., Maynard MJ; Neuroscience and Mental Health Discovery Research Department, Boehringer Ingelheim Pharma GmbH, Biberach, Germany.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Yebra Garcia L; Neuroscience and Mental Health Discovery Research Department, Boehringer Ingelheim Pharma GmbH, Biberach, Germany.; Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Voehringer P; Neuroscience and Mental Health Discovery Research Department, Boehringer Ingelheim Pharma GmbH, Biberach, Germany., Ferger B; Neuroscience and Mental Health Discovery Research Department, Boehringer Ingelheim Pharma GmbH, Biberach, Germany.; Ulm University Medical Center, Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm, Germany., Becker M; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH, Biberach, Germany., Wotjak CT; Neuroscience and Mental Health Discovery Research Department, Boehringer Ingelheim Pharma GmbH, Biberach, Germany., du Hoffmann J; Neuroscience and Mental Health Discovery Research Department, Boehringer Ingelheim Pharma GmbH, Biberach, Germany. johann_faustus.du_hoffmann@boehringer-ingelheim.com. |